Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
  • B01J31/26—Catalysts comprising hydrides, coordination complexes or organic compounds containing in addition, inorganic metal compounds not provided for in groups B01J31/02 - B01J31/24
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
  • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
  • B01J31/22—Organic complexes
  • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
  • B01J31/2208—Oxygen, e.g. acetylacetonates
  • B01J31/2226—Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
  • B01J31/2243—At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
  • B01J31/40—Regeneration or reactivation
  • B01J31/4015—Regeneration or reactivation of catalysts containing metals
  • B01J31/4023—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper
  • B01J31/403—Regeneration or reactivation of catalysts containing metals containing iron group metals, noble metals or copper containing iron group metals or copper
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
  • B01J2231/40—Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
  • B01J2231/48—Ring-opening reactions
  • B01J2231/482—Ring-opening reactions asymmetric reactions, e.g. kinetic resolution of racemates
  • B01J2231/485—Ring-opening reactions asymmetric reactions, e.g. kinetic resolution of racemates kinetic resolution of epoxide racemates
  • B01J2231/487—Ring-opening reactions asymmetric reactions, e.g. kinetic resolution of racemates kinetic resolution of epoxide racemates by hydrolysis
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
  • B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
  • B01J23/74—Iron group metals
  • B01J23/75—Cobalt
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
  • B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
  • B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
  • B01J2531/0252—Salen ligands or analogues, e.g. derived from ethylenediamine and salicylaldehyde
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
  • B01J2531/62—Chromium
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/60—Complexes comprising metals of Group VI (VIA or VIB) as the central metal
  • B01J2531/64—Molybdenum
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/70—Complexes comprising metals of Group VII (VIIB) as the central metal
  • B01J2531/72—Manganese
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
  • B01J2531/84—Metals of the iron group
  • B01J2531/842—Iron
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
  • B01J2531/84—Metals of the iron group
  • B01J2531/845—Cobalt
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
  • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
  • B01J2531/84—Metals of the iron group
  • B01J2531/847—Nickel

Definitions

• the present invention relates to new chiral salen catalysts and methods for the preparation of chiral compounds from racemic epoxides by using new catalyst. More particularly, the present invention is to provide novel chiral salen catalysts and their uses for producing chiral compounds having high optical purity to be used as raw materials for preparing chiral medicines or food additives in a large scale economically, wherein the chiral salen catalyst having a particular molecule structure can be reused continuously without any activating process of used catalysts and cause no or little racemization after the reaction is completed, because it maintains its catalytic activity after the reaction process.
• a preparation method of chiral epichlorohydrins as one of chiral expoxides is disclosed using microorganism in EP Patent No. 431,970 and JP Patent Publication Nos. 90- 257895 and 94-211822. However, it is not recommended because the productivity is low and it, further, requires more than two-step process.
• Another preparation method of chiral epichlorohydrins from chiral sulfonyloxyhaloalcohol derivatives obtained from mannitol derivatives is disclosed in USP 4, 408, 063; and J. Org. chem . , Vol 43, 4876, 1978.
• Methods for preparing chiral expoxides generally use a chiral catalyst having stereoselectivity which hydrolyzes stereoselectively only one isomer from racemic epoxides mixed 50 and 50 of each isomer and leaves the un-hydrolyzed isomer in the reaction medium.
• the chiral catalyst used for said stereoselective hydrolysis is required to be economical, have high stereoselectivity and be re-usable without employing activation process, thus suitable for the industrial purpose.
• Stereoselective hydrolyses of chiral epoxides using chiral salen catalyst as a chiral catalyst are recently disclosed in Science, Vol.
• this method also has a fatal drawback for mass- production of chiral compounds.
• this hydrolysis is performed for mass production, the racemization of the product becomes deepened since it takes longer to perform the distillation to obtain the desired product, thus resulting in decrease of optical purity of the chiral epoxide. Therefore, the use of chiral salen catalyst in the production of chiral epoxides is limited for the above-mentioned reasons .
• the technique for preparing chiral compounds having a high optical purity, which is sufficient for the materials for medicines, in the present invention is distinct, efficient and different from the preparation techniques which only focus on heightening the ratio of the desired stereoisomer in the racemic compounds .
• the present invention has been resulted from resolving deactivation of chiral catalysts and racemization of chiral products because conventional chiral salen catalysts having an acetate group (OAc) or a halogen group loose their activities or functional groups such as acetate groups or halogen groups thereof, which cause racemization of chiral products.
• OAc acetate group
• halogen group loose their activities or functional groups such as acetate groups or halogen groups thereof, which cause racemization of chiral products.
• chiral catalysts having nucleophilic groups such as acetate and halogen group as counterions deteriorate the optical purity of products since these counterions have weak bonds to the center metal and some dissociated counterions participate in the reverse reaction of the hydrolyzed product, 1,2- diols, resulting in the racemization of the chiral products and further, counterions bonded weakly to the center metal in chiral catalysts can be dissociated during the reaction process, resulting in diminished catalytic activity.
• the present invention provides novel chiral salen catalysts comprising one molecule of LQ 3 wherein L is boron (B) or aluminium (Al) ; and Q is a halogen atom selected from the group consisting of F, Cl, Br and I, and two molecules of chiral salen ligands .
• the chiral salen catalyst of the present invention has an activating group of LQ.3, most preferably BF 3 , having no nucleophilic property, which does not affect racemization of chiral epoxides and loose its activity after the reaction is completed.
• an object of the present invention is to provide chiral salen catalysts which not only maintain its ⁇ excellent activity after used, thus being used continuously without activation process and simplifing the manufacturing process but also contribute to produce high optical purity of the product without racemization.
• Another object of the present invention is to provide an economical process for preparing chiral epoxides and chiral 1,2-diols to be used as raw materials for chiral medicines or food additives from racemic epoxides by using said chiral salen catalyst in high yield and high optical purity.
• Fig. 1 is a graph comparing the difference in the reaction rate by employing a representative chiral salen catalyst (I-RR-1) of the present invention and a comparative catalyst 1 having the same 3-dimensional structure as the conventional catalyst over reaction time;
• Fig. 2 is a graph comparing the difference in kinetics of the reaction by employing a representative chiral salen catalyst (I-RR-1) of the present invention and a comparative catalyst 1 having the same 3-dimensional structure as the conventional catalyst;
• Fig. 3 is a graph showing the optical purity of chiral products produced by employing a representative chiral salen catalyst (I-RR-1) of the present invention according to the number of times it is used;
• Fig. 4 is a graph showing the optical selectivity of a conventional chiral salen catalyst having an acetate group (OAc), comparative catalyst 2, according to the number of times it is used;
• FIG. 5 is a graph comparing the difference in degree of the racemization of chiral epoxides produced by employing a representative chiral salen catalyst (I-RR-1) of the present invention, a chiral salen catalyst having an acetate group (comparative catalyst 2) , and a chiral salen catalyst having a bromide group (Br, comparative catalyst 3) over reaction time;
• Fig. 6 is a graph comparing the difference in the reactivity of a representative chiral salen catalyst (I-RR- 1) of the present invention and catalysts prepared by combining chiral salen ligand (3-RR-l) and boron trifluoride in varied ratios;
• Fig. 7 is a graph comparing the difference in the reactivity of a representative chiral salen catalyst (I-RR- 1) of the present invention prepared by mixing a comparative catalyst 1 and a chiral salen ligand (3-RR-l) in the same number of moles to have a ratio between ligand and BF 3 of 2:1, and a mixture of a comparative catalyst 2 and a chiral salen ligand (3-RR-l) in the same number of moles to have a ratio between ligand and OAc of 2:1, and a comparative catalyst 1;
• Fig. 8 is a graph comparing the difference in the reaction rate by employing a chiral salen catalyst comprising chiral salen ligands (3-RR-l) and each one of
• Fig. 9 is a graph comparing the difference in the reaction rate by employing a catalyst comprising chiral salen ligand (3-RR-l) and BC1 3 mixed in a ratio of 2:1 and a comparative catalyst comprising chiral salen ligand (3-RR-l) and BC1 3 mixed in a ratio of 1:1 which has the same 3- dimensional structure as the conventional catalyst.
• Fig. 10 is a graph comparing the difference in the reaction rate by employing a catalyst comprising chiral salen ligand (3-RR-l) and AICI 3 mixed in a ratio of 2:1 and a comparative catalyst comprising chiral salen ligand (3-RR- 1) and AICI 3 mixed in a ratio of 1:1 which has the same 3- dimensional structure as the conventional catalyst.
• the present invention is to provide new structural chiral salen catalysts comprising two molecules of chiral salen ligands and one molecule of LQ 3 expressed by the following formula 1, [formula 1]
• Yi and Y 2 are independently H, Ci-C ⁇ alkyl group, C 2 -C 6 alkenyl group, C 2 -Cg alkynyl group, Ci-C ⁇ alkoxy group, halogen atom, hydroxy group, amino group, thiol group, nitro group, amine group, imine group, amide group, carbonyl group, carboxy group, silyl group, ether group, thio ether group, seleno ether group, ketone group> aldehyde group, ester group, phosphoryl group, phosphonate group, phosphine group, sulfonyl group or (CH 2 )k-R 4 , wherein, R is phenyl, cycloalkyl, cycloalkenyl, heterocycle or polycycle, and k is an integer of 0 to 8, or any two or more neighboring Ri, R 2 , R' ⁇ , R' 2 , X l X 2 , X 3 ,
• X l r X 2 , X 3 , X 4 , X 5 , X 6 , v, X 8 , Yi and Y 2 are independently selected from a group of H, Ci-C ⁇ alkyl group and C ⁇ C6 alkoxy group, and most preferably, Xi, X 2 ,
• X 3 , X, X 5 , X ⁇ , X 7 and X 8 are independently H or t-butyl group, and both Yi and Y 2 are H.
• R and R' may be the same or different, preferably the same; R 2 and R' 2 may be the same or different, preferably the same.
• Ri is identical with R' ⁇
• R 2 is identical with R' 2
• the chiral center forms RR or SS configurations.
• Ri is identical with R' ⁇
• R 2 is identical with R' 2
• the chiral center forms RR or SS configurations.
• R 2 , R' ⁇ and R' 2 are as follows; Ri and R r are combined to form a C 4 -C 6 carbocycle, and R 2 and R' 2 are H, C -C alkyl group or C ⁇ -C 6 alkoxy group; or R' 1 and Ri are H, C ⁇ -C 6 alkyl group or Ci-C ⁇ alkoxy group, and R 2 and R' 2 are combined to form a C 4 -C 6 carbocycle.
• Preferable examples of the metal atom include Mn and
• LQ3 may include BF 3 , BCI 3 , BBr 3 , BI 3 and
• the present invention performs in the presence of said chiral salen catalyst of formula 1.
• the present invention is described in detail as set forth hereunder.
• the present invention relates to the process for preparing optically pure epoxides or 1,2-diols from racemic epoxides by stereoselective hydrolysis in the presence of the chiral salen catalyst of formula 1 in high yield, where the catalyst can be reused continuously without an activation process after used and does not affect racemization of the produced products.
• the chiral salen catalyst of the present invention comprises one molecule of activating group of LQ 3 having no nucleophilic property, preferably BF 3 , and two molecules of chiral salen ligands to prevent from the racemization of the chiral product, thus resulting high optical purity and high yield and further, to prevents the decrease of catalyst activation caused by the dissociation of counterions .
• the catalysts of formula la and formula lb are preferable, [formula la]
• n is an integer of 0 to 4.
• the chiral salen catalyst of formula 1 in accordance with the present invention can be prepared by first reacting the compound of formula 2 with metal acetate in a proper organic solvent, followed by filtering it to obtain a solid compound of formula 3, and then reacting the resulted compound with LQ 3 (for example, BF 3 , BC1 3 , BBr 3 , BI 3 or A1C1 3 ) in a proper organic solvent.
• LQ 3 for example, BF 3 , BC1 3 , BBr 3 , BI 3 or A1C1 3
• Ri, R 2 , R' ⁇ , R' 2 , R 3 , Xi, X 2 , X 3 , X 4 , s, Xe, X?, ⁇ r Yi, Y 2 , M, n, L and Q are as defined in the above formula 1.
• the compound of formula 2 used in the preparation of the chiral salen catalyst of formula 1 can be easily purchased or prepared by a known method disclosed in J. Org. Chem., Vol. 59, 1939, 1994.
• LQ 3 such as BF 3 , BC1 3 , BBr 3 , BI 3 or A1C1 3 can be added in various forms including a hydrated form or a complex.
• boron trifluorides include boron trifluoride dihydrate, boron trifluoride-acetic acid complex, boron trifluoride t-butyl methyl etherate, boron trifluoride dibutyl etherate, boron trifluoride diethyl etherate, boron trifluoride dimethyl etherate, boron trifluoride-ethylamine complex, boron trifluoride-methanol complex, boron trifluoride-methyl sulfide complex, boron trifluoride-phenol complex, boron trifluoride-phosphoric acid complex, boron trifluoride-propanol complex, and boron trifluoride -tetrahydrofuran complex.
• the chiral salen catalyst of formula 1 can be used as it is or by immobilizing on the stationary phase such as zeolite and silica gel. Such immobilization can be obtained by physical absorption or by chemical bonding using rinkers or spacers.
• R is C ⁇ -C ⁇ o alkyl group, C 2 -C6 alkenyl group, C 2 -C6 alkynyl group, C 3 -C 8 cycloalkyl group, Ci-Cio alkoxy group, phenyl group, carbonyl group, carboxy group, ketone group, aldehyde group, ester group, phosphoryl group, phosphonate group, phosphine group, sulfonyl group or (CH 2 ) ⁇ -R5 (wherein, R 5 is C 2 -C 6 alkenyl group, C 2 -C 6 alkynyl group, C 2 -C 6 alkoxy group, phenyl, cycloalkyl, cycloalkenyl, heterocycle, polycycle, halogen atom, hydroxy group, amino group, thiol group, nitro group, amine group, imine group, amide group, carbonyl group, carboxy group, silyl group, ether group, thi
• the stereoselective hydrolysis of scheme 2 comprises steps of reacting racemic epoxide of formula 4 with water in the presence of chiral salen catalyst of formula 1; selectively hydrolyzing either (R) -epoxide or (S) -epoxide; and subsequently separating the unhydrolyzed epoxide from the hydrolyzed epoxide.
• the stereoselective hydrolysis of Scheme 2 is described in more detail hereinafter.
• Racemic epoxide compound of formula 4 0.3-0.8 equivalents of water and over 0.001 mol% of a chiral salen catalyst of formula 1, preferably 0.1-5 mol%, are reacted
• the unhydrolyzed epoxide is separated out by fractional distillation or thin film evaporator at a low temperature of -10 to 50 °C and the chiral 1,2-diol is extracted with an organic solvent from the residue.
• the recovered catalyst is re-used for hydrolysis of fresh racemic epoxide to produce chiral epoxide or chiral 1,2-diol without any activation process.
• the chiral salen catalysts of formula 1 having RR configuration (hereafter referring to as "I-RR") produce (R) -epoxides or (S) -1, 2-diols
• the chiral salen catalysts of formula 1 having SS configuration (hereafter referring to as "I-SS”) produce (S) -epoxides or (R) -1, 2-diols.
• Fig. 1 is a graph comparing the difference in the reaction rate by employing a representative chiral salen catalyst (I-RR-1) of the present invention and a comparative catalyst 1 having the same 3-dimensional structure as the conventional catalyst over reaction time. According to Fig. 1, the catalyst of the present invention has a reaction rate much higher than that of the comparative catalyst 1.
• Fig. 2 is a graph comparing the difference in kinetics of the reaction by employing a representative chiral salen catalyst (I-RR-1) of the present invention and a comparative catalyst 1 having the same 3-dimensional structure as the conventional catalyst.
• rate data obtained with the representative chiral salen catalyst (I-RR-1) of the present invention has a linear correlation with positive slope and nonzero Y-intercept, wherein the X axis is the concentration of the catalyst and the Y axis is the value of the reaction rate divided by the concentration of the catalyst.
• Indication of this graph is consistent with participation of both intramolecular pathway and intermolecular pathway as shown in the following Equation 1.
• Fig. 3 is a graph showing the reaction rate by employing a representative chiral salen catalyst (I-RR-1) of the present invention according to the number of times it is used and
• Fig. 4 is a graph showing the reaction rate by employing a conventional chiral salen catalyst having an acetate group (OAc), comparative catalyst 2, according to the number of times it is used.
• OAc acetate group
• the use of the chiral salen catalyst of the present invention exhibits higher optical purity (over 99%ee) of the chiral epoxides than that of the comparative catalyst 2 having an acetate group. It is further proved that the chiral salen catalyst of the present invention can be reused continuously without any activation process, while the conventional chiral salen catalyst having an acetate group has to be activated with acetic acid after each use because it looses its catalytic activity and the reaction using recovered catalyst takes much longer to obtain over 99%ee of optical purity of the product than that using a fresh catalyst (see Table 1) .
• Fig. 5 is a graph comparing the difference in degree of the racemization of chiral epoxides produced by employing a representative chiral salen catalyst (I-RR-1) of the present invention, a chiral salen catalyst having an acetate group (comparative catalyst 2) , and a chiral salen catalyst having a bromide group (Br, comparative catalyst 3) over reaction time.
• Fig. 6 is a graph comparing the difference in the reactivity of a representative chiral salen catalyst (I-RR- 1) of the present invention and catalysts prepared by combining chiral salen ligand (3-RR-l) and boron trifluoride in varied ratios.
• I-RR- 1 representative chiral salen catalyst
• 3-RR-l chiral salen ligand
• boron trifluoride boron trifluoride
• Fig. 7 is a graph comparing the difference in the reactivity of chiral salen catalyst prepared by mixing a comparative catalyst 1 with the same mole of chiral salen ligand (3-RR-l) and a comparative catalyst prepared by mixing a comparative catalyst 2 with the same mole of chiral salen ligand (3-RR-l) to be the ratio of ligand and BF 3 (or OAc) of 2:1 in order to have the same structure of the chiral salen catalyst of the present invention comprising two molecules of chiral salen ligand and one molecule of BF 3 .
• Fig. 7 is a graph comparing the difference in the reactivity of chiral salen catalyst prepared by mixing a comparative catalyst 1 with the same mole of chiral salen ligand (3-RR-l) and a comparative catalyst prepared by mixing a comparative catalyst 2 with the same mole of chiral salen ligand (3-RR-l) to be the ratio of ligand and BF 3 (or
• the chiral salen catalyst prepared by mixing a comparative catalyst 1 with the same mole of chiral salen ligand (3-RR-l) exhibits superior efficiency when the ratio of Co (salen) represented by formula 3-RR-l and BF 3 is 2:1 unlike the comparative catalyst 2. Therefore, it duly illustrates that the chiral salen catalyst of the present invention (I-RR-1) has not only a different 3-dimensional structure from the conventional chiral salen catalyst but also a different reaction mechanism where BF 3 participates from the conventional ones.
• Fig. 8 is a graph comparing the difference in the reaction rate by employing a chiral salen catalyst comprising two molecules of chiral salen ligands (3-RR-l) and one molecule of BF 3 , BC1 3 , A1C1 3 , B(0Ph) 3 , or B(0Me) 3 mixed in a ratio of 2:1.
• Fig. 9 is a graph comparing the difference in the reaction rate by employing the catalyst comprising chiral salen ligand (3-RR-l) and BCI 3 mixed in a ratio of 2:1 and a comparative catalyst comprising chiral salen ligand (3-RR-l) and BC1 3 mixed in a ratio of 1:1 which has the same 3-dimensional structure as the conventional catalyst.
• Fig. 9 is a graph comparing the difference in the reaction rate by employing the catalyst comprising chiral salen ligand (3-RR-l) and BCI 3 mixed in a ratio of 2:1 and a comparative catalyst comprising chiral salen lig
• FIG. 10 is a graph comparing the difference in the reaction rate by employing the catalyst comprising chiral salen ligand (3-RR-l) and AICI 3 mixed in a ratio of 2:1 and a comparative catalyst comprising chiral salen ligand (3-RR-l) and A1C1 3 mixed in a ratio of 1:1 which has the same 3-dimensional structure as the conventional catalyst.
• the chiral salen catalysts having 6 valence electrons such as B and Al are more effective.
• the chiral salen catalysts prepared by employing B(0Me) 3 , which has a weak strength in withdrawing electrons, or B(OPh) 3 , which has a bulky group shows a relatively slow reaction rate. Further, in Figs. 9 and 10, the chiral salen catalysts of the present invention exhibit remarkably faster reaction rate compared to ones having the same 3-dimensional structure as the conventional catalyst.
• IR(cm-l) 970, 1010, 1070, 1100, 1220, 1270, 1360, 1560, 1720 cm "1 ;
• the recovered catalyst without any activation process was reused for another hydrolysis reaction of racemic epichlorohydrin continuously to obtain (R) [or (S)]- epichlorohydrin with over 99.3 %ee of optical purity (yield: higher than 80%) for more than 10 times.
• (S) -epichlorohydrin was prepared in the same manner as Experimental Example 1 by using 0.4 mol% of the conventional chiral salen catalyst having an acetate group (comparative catalyst 2).
• (S)- epichlorohydrin with 17 %ee of optical purity was prepared.
• the used catalyst was activated by a known method ⁇ Science, Vol. 277, 936, 1997) .
• the used catalyst was added in toluene and 2 equivalents of acetic acid and stirred for 1 hour under atmosphere condition and the solvent was then evaporated under vacuum to obtain recovered catalyst.
• Example 2 Each 0.2 mol% of the catalyst prepared in Example 2 (I-RR-1), 0.4 mol% of the comparative catalyst 2 having an acetate group, and 0.4 mol% of the comparative catalyst 3 having a bromide group was added to 100 g of racemic epichlorohydrin separately and cooled to 5 ° C. 10.7 g of water was slowly added to each reaction mixture of which was stirred at 20 ° C. The optical purity of each reaction mixture was measured over reaction time as shown in Fig. 5.
• Example 5 0.2 mol% of the catalyst prepared in Example 5 and 0.2 mol% of the intermediate of formula 3-RR-I prepared in Example 2 were added to 100 g of racemic epibromohydrin. The reaction mixture was stirred for 10 minutes at room temperature
• Example 7 g of the catalyst prepared in Example 1 (I-SS-1) or Example 2 (I-RR-1) was added to 130 g of racemic styrene oxide and cooled to 5 ° C. 13.6 g of water was slowly added to the reaction mixture, which was stirred at 20 ° C for 15 hours .
• the reaction mixture was performed for fractional distillation under vacuum to obtain first (S) [or (R) ] - styrene oxide with 99 %ee of optical purity (yield: 70%) .
• Dichloromethane and water were added to the residue and extracted out the used catalyst to the dichloromethane layer which was evaporated under vacuum to recover the used catalyst. The recovered catalyst was reused for next reaction without any activation process to produce (S) [or (R) ] -styrene oxide with over 99 %ee of optical purity.
• Example 2 0.2 mol% of the catalyst prepared in Example 2 was mixed with 400 kg of racemic epichlorohydrin and cooled to
• the chiral salen catalyst of the present invention has a different structure from that of the known chiral salen catalysts. Further, the chiral salen catalyst of the present invention can be reused without any activation process, which is a disadvantage associated with conventional chiral salen catalyst, and used effectively in mass production of chiral epoxides or chiral 1,2-dials from racemic epoxides in high yield and high optical purity by s.tereoselective hydrolysis.

Landscapes

• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Materials Engineering (AREA)
• Organic Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Inorganic Chemistry (AREA)
• Catalysts (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Epoxy Compounds (AREA)
• Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Priority Applications (6)

Applications Claiming Priority (4)

Publications (1)

Family

ID=26639176

Family Applications (1)

Country Status (9)

Cited By (5)

Families Citing this family (41)

Citations (1)

Family Cites Families (7)

• 2002
  • 2002-06-26 AU AU2002345388A patent/AU2002345388A1/en not_active Abandoned
  • 2002-06-26 CN CN02802133.9A patent/CN1233648C/zh not_active Expired - Fee Related
  • 2002-06-26 WO PCT/KR2002/001219 patent/WO2003002582A1/en not_active Ceased
  • 2002-06-26 US US10/297,164 patent/US6884750B2/en not_active Expired - Lifetime
  • 2002-06-26 ES ES02743918T patent/ES2217245T3/es not_active Expired - Lifetime
  • 2002-06-26 DE DE60200346T patent/DE60200346T2/de not_active Expired - Lifetime
  • 2002-06-26 JP JP2003508963A patent/JP3968076B2/ja not_active Expired - Fee Related
  • 2002-06-26 EP EP02743918A patent/EP1292602B1/en not_active Expired - Lifetime
  • 2002-06-26 AT AT02743918T patent/ATE263626T1/de not_active IP Right Cessation

Patent Citations (1)

Non-Patent Citations (4)

Also Published As

Similar Documents

Legal Events